(Q74570653)

English

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day

scientific article published on 01 May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

based on heuristic

inferred from title

author name string

M De Backer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C De Vroey

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Lesaffre

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

I Scheys

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

P De Keyser

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Journal of the American Academy of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

38

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

5 Pt 3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S57-63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal activity of the allylamine derivative terbinafine in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New approaches to the treatment of onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of terbinafine in the nail

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Open randomized comparison of itraconazole versus terbinafine in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized treatment duration-finding study of terbinafine in onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis for onychomycosis therapy in Canada from a government perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2898%2970486-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0190-9622(98)70486-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9594939%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74570653&oldid=1933553976"